| Literature DB >> 35181704 |
Rosalia Antunes-Foschini1, João M Furtado2, Manuela Molina Ferreira1,3.
Abstract
There is limited information on functional low vision (FLV) in Latin America, especially in individuals under 50 years of age. In the present study, we retrospectively evaluated the medical records of 1393 consecutive subjects seen at a Brazilian tertiary rehabilitation service, from February 2009 to June 2016. We collected sociodemographic, clinical data, and information on optical aids and spectacle prescription. Subjects were divided into three age groups: 0 to 14 years old (children), 15 to 49 years old (young adults), and 50 years or older (older adults). The main etiologies leading to FLV in children were cerebral visual impairment (27.9%), ocular toxoplasmosis (8.2%), and retinopathy of prematurity (7.8%). In young adults, retinitis pigmentosa (7.4%) and cone/rod dystrophy (6.5%) were the most frequent, while in older adults, age-related macular degeneration (25.3%) and diabetic retinopathy (18.0%) were the leading causes. Our results indicate that preventable diseases are important causes of FLV in children in the area, and proper prenatal care could reduce their burden. The increasing life expectancy in Latin America and the diabetes epidemic are likely to increase the demand for affordable, people-centered rehabilitation centers, and their integration into health services should be planned accordingly.Entities:
Mesh:
Year: 2022 PMID: 35181704 PMCID: PMC8857251 DOI: 10.1038/s41598-022-06798-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart of the subjects included in the study. BCVA best-corrected visual acuity, OU both eyes.
Demographic and clinical characteristics of the subjects studied (n = 1393).
| n = 1393 | n | % | |
|---|---|---|---|
| Sex | Female | 666 | 47.8 |
| Male | 727 | 52.2 | |
| Age (years) | 0–14 | 512 | 36.8 |
| 15–49 | 340 | 24.4 | |
| 50 or more | 541 | 38.8 | |
| Main anatomical site | Retina | 655 | 47 |
| Retrobulbar | 248 | 17.8 | |
| Whole Globe | 157 | 11.3 | |
| Optic Nerve | 113 | 8.1 | |
| Uvea | 101 | 7.2 | |
| Lens | 68 | 4.9 | |
| Cornea | 51 | 3.7 |
n number of subjects.
Frequency of best-corrected visual acuity per age group studied (n = 1393).
| BCVA classification | 0–14 years | 15–49 years | 50 years or more | |||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| BCVA < 6/18 to 6/60 | 132 | 25.8 | 131 | 38.5 | 184 | 34.0 |
| BCVA < 6/60 to 3/60 | 65 | 12.7 | 95 | 27.9 | 195 | 36.0 |
| BCVA < 3/60 to 1/60 | 19 | 3.7 | 51 | 15.0 | 85 | 15.8 |
| BCVA < 1/60 to light perception | 30 | 5.9 | 59 | 17.4 | 77 | 14.2 |
| Unable to inform BCVA | 266 | 51.9 | 4 | 1.2 | 0 | 0 |
n number of subjects, BCVA best-corrected visual acuity.
Figure 2Subjects with functional low vision per age group.
Causes of functional low vision divided per age group (n = 1393).
| 0–14 years (n = 512) | n (%) | 15–49 years (n = 340) | n (%) | 50 years or more (n = 541) | n (%) |
|---|---|---|---|---|---|
| Cerebral Visual Impairment | 143 (27.9) | Retinitis Pigmentosa | 25 (7.4) | AMD | 141 (26.1) |
| Ocular Toxoplasmosis | 42 (8.2) | Cone/Rod Dystrophy | 22 (6.5) | Diabetic Retinopathy | 98 (18.1) |
| ROP | 40 (7.8) | Cong. Glaucoma Other Glaucomas | 21 (6.2) | Glaucoma | 60 (11.1) |
| Cong. Cataract | 37 (7.2) | Degenerative Myopia | 21 (6.2) | Degenerative Myopia | 31 (5.7) |
| Ocular Malformations | 30 (5.9) | Ocular Toxoplasmosis | 21 (6.2) | Retinitis Pigmentosa | 23 (4.2) |
| Cong. Glaucoma / Other Glaucomas | 30 (5.9) | Cong. Cataract | 20 (5.9) | Retinal Detachment | 21 (4.1) |
| Nystagmus / Strabismus | 29 (5.7) | Diabetic Retinopathy | 18 (5.3) | Other Maculopathies | 20 (3.9) |
| Albinism | 18 (3.5) | Other Maculopaties | 16 (4.7) | Corneal Opacity | 12 (2.2) |
| Cong. Infection (Toxoplasmosis excluded) | 15 (2.9) | Corneal Opacity | 12 (3.5) | Macular Hole | 10 (1.8) |
| Cone/Rod Dystrophy | 14 (2.7) | Retinal Detachment | 12 (3.5) | Alcohol-Tobacco Neuropathy | 9 (1.6) |
| Optic Nerve Hypoplasia | 12 (2.3) | Albinism | 10 (2.9) | Anterior Ischemic Optic Neuropathy | 9 (1.6) |
| Other Retina Diseases | 51(10.0) | Keratoconus | 10 (2.9) | Ocular Toxoplasmosis | 8 (1.4) |
| Other Optic Nerve Diseases | 20 (3.9) | Optic Nerve Compression | 9 (2.7) | Other Retina/Choroid diseases | 40 (7.4) |
| Other Anterior Segment Diseases | 18 (3.5) | Other Optic Nerve Diseases | 44 (12.9) | Other Optic Nerve Diseases | 21 (3.8) |
| Othera | 13 (2.6) | Other Retinal Diseases | 27 (7.9) | Other Anterior Segment Diseases | 10 (1.8) |
| Otherb | 58 (17.0) | Otherc | 28 (5.2) |
AMD Aged-Related Macular Disease, ROP Retinopathy of Prematurity, Cong Congenital.
aLow vision with no defined etiology (6); acquired central nervous system infection (6); chronic uveitis associated with juvenile idiopathic arthritis (1).
bLow vision with no defined etiology (12); nystagmus (8) ocular malformation (8); central nervous system infection (7); central nervous system stroke (5); cerebellar ataxia (5); traumatic brain injury (4); amblyopia due to high ametropia (2); acquired choroidopathy (3); ocular trauma (3), cerebral palsy (2); ocular tumor (1); sympathetic ophthalmia (1).
cLow vision with no defined etiology (9); central nervous system stroke (7); ocular trauma (4); uveitis with no defined etiology (2); traumatic brain injury (2); amblyopia due to high ametropia (1); ischemic ocular syndrome (1); congenital infection (1); ocular malformation (1).
Prescription and acquisition of spectacles and optical devices per age group (n = 1393).
| 0–14 years n = 512 | 15–49 years n = 340 | 50 years or more | |||||
|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | ||
| Spectacles n = 397 | Prescription | 154 | 30.1 | 108 | 31.8 | 135 | 24.9 |
| Acquired with own resources | 24 | 15.6 | 88 | 81.5 | 54 | 40.0 | |
| Donation | 25 | 16.2 | 7 | 6.5 | 4 | 3.0 | |
| Unacquired | 105 | 68.2 | 13 | 12.0 | 77 | 57.0 | |
| Optical Devices n = 609 | Prescription | 157 | 30.6 | 188 | 55.3 | 264 | 48.8 |
| Acquired with own resources | 12 | 7.6 | 39 | 20.7 | 127 | 48.1 | |
| Donation | 106 | 67.5 | 99 | 52.7 | 113 | 42.8 | |
| Unacquired | 39 | 24.8 | 50 | 26.6 | 24 | 9.1 | |
n number of subjects.
Type and number of donated optical devices and spectacles.
| Optical device | n | % |
|---|---|---|
| 3 × 20 mm | 3 | 3.8 |
| 4 × 12 mm | 57 | 73.1 |
| 6 × 16 mm | 16 | 20.5 |
| 8 × 21 mm | 2 | 2.6 |
| + 8ED bar magnifier | 3 | 1.2 |
| + 8ED Neck loupe | 2 | 0.8 |
| + 10ED hand magnifier | 27 | 1.5 |
| + 12ED clip on | 2 | 0.8 |
| + 16ED stand magnifier | 104 | 44.3 |
| + 20ED hand magnifier | 49 | 20.9 |
| + 28ED stand magnifier with light | 7 | 3 |
| + 38ED stand magnifier with light | 14 | 6 |
| + 50ED stand magnifier with light | 27 | 11.5 |
| Spheric-prismatic lenses | 30 | 19.7 |
| Aspheric diopters (monocular) | 30 | 19.7 |
| Negative lenses | 24 | 15.8 |
| Filter lenses | 23 | 15.1 |
| Aspheric diopters (binocular) | 23 | 15.1 |
| Bifocal lenses with addition of up to + 4,0ED | 17 | 11.2 |
| Bifocal lenses with addition greater than + 4,0ED | 3 | 2 |
| Microscopic lenses | 2 | 1.3 |
ED spherical diopters.